147 related articles for article (PubMed ID: 14654475)
1. Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Damdinsuren B; Nagano H; Sakon M; Kondo M; Yamamoto T; Umeshita K; Dono K; Nakamori S; Monden M
Ann Surg Oncol; 2003 Dec; 10(10):1184-90. PubMed ID: 14654475
[TBL] [Abstract][Full Text] [Related]
2. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
3. Role of p53 in the inhibitory effects of interferon-alpha subtypes on proliferation of hepatocellular carcinoma cells.
Fujioka N; Ariyasu T; Arai N; Ariyasu H; Yamamoto S; Tanimoto T; Ikegami H; Ikeda M; Ohta T; Fukuda S; Kurimoto M
Biomed Res; 2006 Oct; 27(5):219-26. PubMed ID: 17099286
[TBL] [Abstract][Full Text] [Related]
4. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
[TBL] [Abstract][Full Text] [Related]
5. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
[TBL] [Abstract][Full Text] [Related]
6. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Eguchi H; Nagano H; Yamamoto H; Miyamoto A; Kondo M; Dono K; Nakamori S; Umeshita K; Sakon M; Monden M
Clin Cancer Res; 2000 Jul; 6(7):2881-90. PubMed ID: 10914738
[TBL] [Abstract][Full Text] [Related]
10. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
[TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Nagano H; Wada H; Tomokuni A; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Br J Cancer; 2010 Nov; 103(10):1617-26. PubMed ID: 20978511
[TBL] [Abstract][Full Text] [Related]
13. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
14. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
[TBL] [Abstract][Full Text] [Related]
16. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
Hung WC; Chuang LY
Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
[TBL] [Abstract][Full Text] [Related]
19. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Wada H; Noda T; Murakami M; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Br J Cancer; 2010 May; 102(10):1483-90. PubMed ID: 20407444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
